SC
BIO icon

Sepio Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sepio Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,360
Closed -$793K – 341
2020
Q4 		$793K Sell
1,360
-453
-25% -$258K 0.07% 251
2020
Q3 		$935K Hold
1,813
– – 0.1% 174
2020
Q2 		$819K Sell
1,813
-768
-30% -$339K 0.1% 173
2020
Q1 		$905K Sell
2,581
-12
-0.5% -$4.41K 0.12% 130
2019
Q4 		$959K Sell
2,593
-131
-5% -$46.2K 0.09% 156
2019
Q3 		$906K Buy
2,724
+163
+6% +$53.2K 0.09% 156
2019
Q2 		$801K Buy
2,561
+7
+0.3% +$2.1K 0.11% 152
2019
Q1 		$781K Sell
2,554
-43
-2% -$11.6K 0.11% 153
2018
Q4 		$603K Buy
+2,597
New +$697K 0.04% 174

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Sepio Capital's BIO Position: Q1 2021 in Review

Sepio Capital sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2021, closing a stake of 1,360 shares — an estimated $793K sold.

Sepio Capital first reported a position in BIO in Q4 2018 and held it in 9 quarters. The position peaked at $959K in Q4 2019. 491 funds tracked by Wall St. Rank hold BIO as of Q1 2021.

  • Sepio Capital reported no remaining Bio-Rad Laboratories Class A position as of Q1 2021 after selling out during the quarter.
  • Sepio Capital sold 1,360 Bio-Rad Laboratories Class A shares in Q1 2021, an estimated $793K.
  • Sepio Capital first reported a position in Bio-Rad Laboratories Class A in Q4 2018 and held it in 9 quarters.
  • Sepio Capital's Bio-Rad Laboratories Class A position peaked at $959K in Q4 2019.
  • 491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2021.

Based on Sepio Capital's 13F filing for Q1 2021, filed 10 May 2021.